ABO-Incompatible Platelet Transfusions and Mortality Risk in Patients With Intracranial Hemorrhage

Read full text Summarise with VIRAT
Authors: David Jinou Roh, Jonathan M. Davis, Deborah B. Bookwalter, Travis Lee, Patrick Mitchell, Elizabeth F. Stone, Matthew S. Karafin, Melissa M. Cushing, Grant P. Sinson, Claude Hemphill, Emily J. Gilmore, Bryan Spencer
+5 more Jerome L. Gottschall, Alan E. Mast, Ritchard G. Cable, Steven H Kleinman, Eldad A. Hod
Cited by: 0
References: 29

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND AND OBJECTIVES: Best platelet transfusion practices are unclear across intracranial hemorrhage (ICH) types, given the mortality risk. Reasons for this risk are unknown, but ABO-incompatible platelet transfusions may confer risk in certain populations. We assessed contemporary ICH platelet transfusion practices and whether ABO-incompatible platelet transfusions increase ICH mortality risk. METHODS: Adult patients with spontaneous intracerebral hemorrhage (sICH), traumatic ICH, and aneurysmal subarachnoid hemorrhage hospitalizations between 2019 and 2024 were assessed from a multicenter transfusion network. Relationships of platelet transfusions with 30-day mortality were assessed using logistic regression models adjusting for demographics, ICH type/severity, comorbidities, and other hemorrhage control therapies/transfusions. Among those receiving platelet transfusions, relationships of major ABO-incompatible platelet units with mortality risk were investigated using Cox models adjusting for similar covariates. Analyses were performed across the cohort and stratified by ICH subtype. RESULTS: Among 13 068 patients with ICH, 60% were male individuals, mean age was 66 (±19) years, 23% were from sICH, 69% from traumatic ICH, and 8% from aneurysmal subarachnoid hemorrhage cohorts. Acute platelet transfusions were given to 12% of the patients. Thrombocytopenia (

Fields of Study & Subjects

Blood transfusion and management Intracerebral and Subarachnoid Hemorrhage Research Trauma Hemostasis Coagulopathy Resuscitation

Publication details

Journal / source
Neurosurgery
Volume
99
Issue
6
Pages
1460–1469
Publication date
27 March 2026
Language
EN